Switching and combining dopamine agonists.
Switching from one dopamine agonist to another is common practice in the treatment of patients with Parkinson's disease. This paper describes some ideas on the most practical way to perform switching. In addition, it describes the possibilities of combining various dopamine agonists and discusses pros and cons for doing so.
Reichmann
H
H
Department of Neurology, Technical University of Dresden, Dresden, Germany. Heinz.Reichmann@mailbox-tu-dresden.de
Herting
B
B
Mïller
A
A
Sommer
U
U
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'
D000978:Antiparkinson Agents; D018491:Dopamine Agonists